“RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: CHEMOIMMUNOTHERAPY, TREATMENT UNTIL PROGRESSION WITH MECHANISM-DRIVEN AGENTS OR FINITE-DURATION THERAPY?”, Mediterr J Hematol Infect Dis, vol. 11, no. 1, p. e2019024, Feb. 2019, doi: 10.4084/mjhid.2019.024.